SCHEMBL8006941

SCHEMBL8006941

CC(C)c1cccc(COC(=O)NC(=N)N)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAU P00749 1/20 0.40
MEN1 O00255 1/20 0.40
LMNA P02545 1/20 0.40
KMT2A Q03164 1/20 0.40
MRGPRX4 Q96LA9 1/20 0.40
POLB P06746 1/20 0.39
PTGER3 P43115 1/20 0.39
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MDM4 O15151 1/20 0.38
ALDH1A1 P00352 1/20 0.38
TP53 P04637 1/20 0.38
CYP3A4 P08684 1/20 0.38
MAPT P10636 1/20 0.38
TYR P14679 1/20 0.38
HPGD P15428 1/20 0.38
ALOX15 P16050 1/20 0.38
ALOX12 P18054 1/20 0.38
CA5A P35218 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7995206 0.99 PLAU (0.39) PLAUMEN1LMNAKMT2AMRGPRX4
SCHEMBL15592216 0.80 HTT (0.45) MEN1LMNAKMT2AMRGPRX4CYP3A4
SCHEMBL8098924 0.79 MRGPRX4 (0.40) MRGPRX4POLBPTGER3CA1CA2
SCHEMBL15592233 0.79 CPB1 (0.51) LMNAHTTSMN1; SMN2
SCHEMBL1763734 0.78 LMNA (0.57) PLAULMNAKMT2APOLBCA1
SCHEMBL15592221 0.78 HTT (0.56) MEN1LMNAKMT2AMAPTHTT
SCHEMBL15592193 0.77 MEN1 (0.54) MEN1LMNAKMT2AALDH1A1CYP3A4
SCHEMBL10053139 0.77 MGLL (0.59) MEN1KMT2APOLBTP53MAPT
SCHEMBL10053141 0.77 ALDH1A1 (0.58) MEN1LMNAKMT2AMRGPRX4PTGER3
Hydrochloric Acid SCHEMBL30443859 0.77 LMNA (0.55) PLAULMNAKMT2APOLBCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0748795-B1 Substituted benzyloxycarbonyl guanidines as Na+/H+ exchange inhibitors, process for their preparation, their use as medicinal or diagnostic agents as well as medicament containing them HOECHST AG (DE) 2000-08-23 EP claimed
EP-0748795-A2 Substituted benzyloxycarbonyl guanidines as Na+/H+ exchange inhibitors, process for their preparation, their use as medicinal or diagnostic agents as well as medicament containing them HOECHST AKTIENGESELLSCHAFT (DE) 1996-12-18 EP claimed
EP-0748795-B1 Substituted benzyloxycarbonyl guanidines as Na+/H+ exchange inhibitors, process for their preparation, their use as medicinal or diagnostic agents as well as medicament containing them HOECHST AG (DE) 2000-08-23 EP disclosed
US-6022899-A EFFECTIVE INHIBITORS OF THE CELLULAR SODIUM PROTON ANTIPORTER HOECHST AKTIENGESELLSCHAFT (DE) 2000-02-08 US disclosed
US-5753710-A INHIBITORS OF THE CELLULAR SODIUM PROTON ANTIPORTER HOECHST AKTIENGESELLSCHAFT (DE) 1998-05-19 US disclosed
EP-0748795-A2 Substituted benzyloxycarbonyl guanidines as Na+/H+ exchange inhibitors, process for their preparation, their use as medicinal or diagnostic agents as well as medicament containing them HOECHST AKTIENGESELLSCHAFT (DE) 1996-12-18 EP disclosed